Drug Trial Radar · NCT02788747
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
Last checked: Nov 20, 2026Latest source record: May 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
Jun 2016
Primary completion
Sep 2017
Study completion Oct 2017
Sponsor
- Lead sponsor
- Stealth BioTherapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 2, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a randomized, double-blinded, placebo-controlled, multiple-dose study in subjects with stable heart failure (HF) with reduced ejection fraction (HFrEF).
Conditions
- Heart Failure
Interventions
4 mg elamipretideDrug
Subcutaneous injection of 4 mg elamipretide administered once daily for 28 consecutive days
40 mg elamipretideDrug
Subcutaneous injection of 40 mg elamipretide administered once daily for 28 consecutive days
PlaceboDrug
Subcutaneous injection of placebo administered once daily for 28 consecutive days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Left Ventricular End Systolic Volume (ml)Time frame: Baseline to Week 4
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
A.O. Papa Giovanni XXIII Cardiologia 1, Torre 5
Bergamo, Italy
A.O. Spedali Civili di Brescia Cardiologia
Brescia, Italy
Azienda Ospedaliera Brotzu Cardiologia
Cagliari, Italy
Centro Cardiologico Monzino U.O. Scompenso, Cardiologia Clinica e Cardiologia Riabilitativa
Milan, Italy
Ospedale Niguarda Ca' Granda SC Cardiologia 2
Milan, Italy
Cardiologia clinica, Unità dello Scompenso e Terapia intensive Reparto Carlo Magno, Faggi Policlinico di Monza
Monza, Italy
Dip. Cardiotoracovascolare: Cardiologia Fondazione IRCCS Policlinico San Matteo Pad. Nuovo Ospedale "DEA" Degenza: PIANO +3 Ambulatori: P.T. e P+3
Pavia, Italy
Fondazione Toscana Gabriele Monasterio per la Ricerca Medica e di Sanità Pubblica
Pisa, Italy
Deventer Hospital, Department of Cardiology
Deventer, Netherlands
University Medical Centre Groningen
Groningen, Netherlands
Anthonius Ziekenhuis, Cardiology Department
Sneek, Netherlands
Elisabeth Twee Steden Hospital (ETZ), Department of Cardiology
Tilburg, Netherlands
Gelre Ziekenhuis Zutphen, Department of Cardiology
Zutphen, Netherlands
Ninewells Hospital and Medical School
Dundee, United Kingdom
William Harvey Heart Centre CRC, (Barts Health NHS Trust)
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.